FDA — authorised 31 December 1987
- Application: NDA019779
- Marketing authorisation holder: HARROW EYE
- Local brand name: IOPIDINE
- Indication: SOLUTION/DROPS — OPHTHALMIC
- Status: approved
🇺🇸 Iopidine in United States
FDA authorised Iopidine on 31 December 1987
Marketing authorisations
FDA — authorised 30 July 1993
- Application: NDA020258
- Marketing authorisation holder: HARROW EYE
- Local brand name: IOPIDINE
- Indication: SOLUTION/DROPS — OPHTHALMIC
- Status: approved
Iopidine in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Cardiovascular approved in United States
Frequently asked questions
Is Iopidine approved in United States?
Yes. FDA authorised it on 31 December 1987; FDA authorised it on 30 July 1993.
Who is the marketing authorisation holder for Iopidine in United States?
HARROW EYE holds the US marketing authorisation.